| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation N6+F?+N1p (25-DEC-05) Donating Investigator Thomas Quertermous, Stanford University School of Medicine Description
Homozygous mice are viable and do not display any behavioral or histological defects. Although homozygotes are fertile, the donating investigator reports decreased fecundity. Northern blot analysis showed no endogenous gene expression in lung, liver, kidney, spleen, or aorta. Homozygotes have increased fasting plasma levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, and phospholipids compared to wild type. Mutant mouse plasma apoA-I is increased while heparin-releasable phospholipase activity is impaired. Homozygous null mice have decreased arterial endothelium monocyte adhesion. This mutant can be used in studies of lipoprotein metabolism, atherosclerotic vascular disease, and other cholesterol-related studies.Development
A targeting vector containing a neomycin resistance gene was used to replace exon 1 of the endogenous gene. The construct was electroporated into 129S6/SvEv-derived TL-1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. A resulting chimeric male was backcrossed to a C57BL/6J female. Heterozygous pups were bred to C57BL/6J for at least six generations before being interbred.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Congenic Nomenclature
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Lipgtm1Tq/Lipg+
B6.129S6-Lipgtm1Tq
- homeostasis/metabolism phenotype
- increased circulating HDL cholesterol level (MGI Ref ID J:81821)
- 25% increase in male but not female mice compared to in wild-type mice
- increased circulating phospholipid level (MGI Ref ID J:81821)
- over 30% increase compared to in wild-type mice
- increased circulating triglyceride level (MGI Ref ID J:81821)
- in female mice but not male mice
Lipgtm1Tq/Lipgtm1Tq
B6.129S6-Lipgtm1Tq
- homeostasis/metabolism phenotype
- increased circulating cholesterol level (MGI Ref ID J:81821)
- both male and female mice exhibit an increase in serum cholesterol (69% increase in male mice) compared to wild-type mice
- increased circulating HDL cholesterol level (MGI Ref ID J:81821)
- 57% increase in male compared to in wild-type mice
- increased circulating phospholipid level (MGI Ref ID J:81821)
- over 50% increase compared to in wild-type mice
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Lipgtm1Tq/Lipgtm1Tq
involves: 129S6/SvEvTac * C57BL/6J
- homeostasis/metabolism phenotype
- increased circulating cholesterol level (MGI Ref ID J:93987)
- increased circulating HDL cholesterol level (MGI Ref ID J:93987)
- increased circulating phospholipid level (MGI Ref ID J:93987)
- increased circulating triglyceride level (MGI Ref ID J:93987)
Lipgtm1Tq/Lipgtm1Tq
involves: 129S6/SvEvTac
- homeostasis/metabolism phenotype
- abnormal circulating HDL cholesterol level (MGI Ref ID J:129942)
- unlike in wild-type mice, HDL levels are not affected by hepatic proprotein convertase inhibition
- cardiovascular system phenotype
- abnormal vascular endothelial cell physiology (MGI Ref ID J:95158)
- isolated aortic strips exhibit decreased monocyte binding compared to wild-type strips
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cardiovascular Research
Atherosclerosis
Hypercholesterolemia
Other (altered lipoprotein profile)
Cell Biology Research
Defects in Cell Adhesion Molecules
| Allele Symbol | Lipgtm1Tq | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Thomas Quertermous | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | LIPG-; | ||
| Mutation Made By | Thomas Quertermous, Stanford University School of Medicine | ||
| Strain of Origin | 129S6/SvEvTac | ||
| ES Cell Line Name | TL1/TL-1 | ||
| ES Cell Line Strain | 129S6/SvEvTac | ||
| Gene Symbol and Name | Lipg, lipase, endothelial | ||
| Chromosome | 18 | ||
| Gene Common Name(s) | 3110013K01Rik; EDL; EL; PRO719; RIKEN cDNA 3110013K01 gene; endothelial lipase; lipase; mEDL; | ||
| Molecular Note | The gene was disrupted by insertion of a neomycin resistance cassette into exon 1 via homologous recombination. Absence of gene expression in homozygous mutant animals was confirmed by Northern blot analysis of lung, kidney, aorta, liver, and heart. [MGI Ref ID J:81821] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Ishida T; Choi S; Kundu RK; Hirata K; Rubin EM; Cooper AD; Quertermous T. 2003. Endothelial lipase is a major determinant of HDL level. J Clin Invest 111(3):347-55. [PubMed: 12569160] [MGI Ref ID J:81821]
Lipgtm1Tq relatedIshida T; Choi SY; Kundu RK; Spin J; Yamashita T; Hirata K; Kojima Y; Yokoyama M; Cooper AD; Quertermous T. 2004. Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279(43):45085-92. [PubMed: 15304490] [MGI Ref ID J:93987]
Jin W; Wang X; Millar JS; Quertermous T; Rothblat GH; Glick JM; Rader DJ. 2007. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6(2):129-36. [PubMed: 17681148] [MGI Ref ID J:129942]
Kojma Y; Hirata K; Ishida T; Shimokawa Y; Inoue N; Kawashima S; Quertermous T; Yokoyama M. 2004. Endothelial lipase modulates monocyte adhesion to the vessel wall. A potential role in inflammation. J Biol Chem 279(52):54032-8. [PubMed: 15485805] [MGI Ref ID J:95158]
Wang X; Jin W; Rader DJ. 2007. Upregulation of macrophage endothelial lipase by toll-like receptors 4 and 3 modulates macrophage interleukin-10 and -12 production. Circ Res 100(7):1008-15. [PubMed: 17347473] [MGI Ref ID J:133915]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as homozygotes, but heterozygous mice have greater fecundity.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.